Abstract:Background: For hepatocellular carcinoma (HCC) patients, surgical resection is the main treatment modality that offers an opportunity for prolonged survival. Tumor recurrence or metastasis after liver resection limits the long-term survival of HCC patients. However, the mechanism of liver regeneration-induced metastasis and augmented growth of residual HCC following liver resection remains obscure. Methods: HCC tissues and matched non-tumor tissues were collected from 75 patients (for mRNA analysis) at the Eastern Hepatobiliary Surgery Hospital from 2008 to 2013. We evaluated the functions of lncRNA-LRAHC through knockdown and overexpression of this lncRNA using lentivirus infection system in vitro and in vivo. Results: In this study, we identified a long noncoding RNA associated with liver regeneration and hepatocellular carcinoma, termed lncRNA-LRAHC, via a liver regeneration microarray (GSE43687). We discovered that lncRNA-LRAHC accelerated hepatocyte proliferation and inhibited HCC cell migration in vitro and in vivo. Mechanistically, we found that lncRNA-LRAHC interacts with RNA-binding protein HuR and enhances XBP1 to promote proliferation during liver regeneration; it combines with protein CDH2 and represses its expression, further altering normal cytoskeleton structure to suppress HCC metastasis. We also found a human ortholog of lncRNA-hLRAHC and determined it was down-regulated in HCC tissues and correlated with poor survival in HCC patients. Conclusions: These data support a crucial function of lncRNA-LRAHC in promoting liver regeneration and tumor suppression in HCC. This indicates a novel therapeutic approach using lncRNA-LRAHC to enhance liver regeneration in HCC patients who undergo liver resection without the risk of cancer recurrence or metastasis. Funding Statement: This work was supported by Grant 81402325, 81874151 from the National Natural Science Foundation of China, Grant 20184Y0241 from Shanghai Municipal Commission of Health and Family Planning. Grant 2016KJ077 from Young Talents Training Moving Program of Tongji University School. Declaration of Interests: The authors have no conflicts to disclose. Ethics Approval Statement: Animal studies were approved by the institutional animal care and use committee of the Fudan University, Shanghai, China.

BLVRA exerts its biological effects to induce malignant properties of hepatocellular carcinoma cells via Wnt/β-catenin pathway

Biliverdin reductase B impairs cholangiocarcinoma cell motility by inhibiting the Notch/Snail signaling pathway

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Identification of CCDC115 As an Adverse Prognostic Biomarker in Liver Cancer Based on Bioinformatics and Experimental Analyses

Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma

Correction For: LncRNA PVT1 Accelerates Malignant Phenotypes of Bladder Cancer Cells by Modulating Mir-194-5p/bclaf1 Axis As a Cerna

BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.

Effect of VEGF165b on biological characteristics of human hepatocellular carcinoma HepG2 cells

Effect of Bax Gene Expression on Cell Invasion in Hepatobiliary Carcinoma Cells

MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma

WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling

Wnt5a Involved In Regulation Of The Biological Behavior Of Hepatocellular Carcinoma

LINC01535 promotes hepatocellular carcinoma proliferation and metastasis by regulating the miR-214-3p/VASP axis

Up-regulated Expression of Phospholipase C, β1 is Associated with Tumor Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma

Up-regulation of S100A4 Expression by HBx Protein Promotes Proliferation of Hepatocellular Carcinoma Cells and Its Correlation with Clinical Survival.

MicroRNA‐127‐5p Targets the Biliverdin Reductase B/nuclear Factor‐κb Pathway to Suppress Cell Growth in Hepatocellular Carcinoma Cells

Bivalent Role of LncRNA-LRAHC during Liver Regeneration and Hepatocellular Carcinoma

Mevalonate pathway inhibition reduces bladder cancer metastasis by modulating RhoB protein stability and integrin β1 localization

Hbx-Associated Long Non-Coding Rna Activated By Tgf-Beta Promotes Cell Invasion And Migration By Inducing Autophagy In Primary Liver Cancer

Effect of hepatitis B virus whole-X gene on HEK293 cells

Over-Expression of BRMS1 Promotes Apoptosis in Human Hepatocellular Carcinoma SK-HEP-1 Cells